Integral Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Integral Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$443K	Buy	2,800 +800	+40%	+$108K	0.1%	121
2026 Q1	$255K	Hold	2,000	–	–	0.06%	153
2025 Q4	$244K	Hold	2,000	–	–	0.06%	159
2025 Q3	$200K	Buy	+2,000	New	+$180K	0.05%	162
2025 Q2	–	Sell	-4,000	Closed	-$324K	–	163
2025 Q1	$324K	Buy	+4,000	New	+$358K	0.1%	125

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Integral Investment Advisors's XBI Position: Q2 2026 in Review

Integral Investment Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 40% in Q2 2026, buying an estimated $108K and bringing the position to 2,800 shares worth $443K. The position accounts for 0.1% of the portfolio, ranked #121.

Integral Investment Advisors first reported a position in XBI in Q1 2025 and has held it in 5 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Integral Investment Advisors held 2,800 shares of State Street SPDR S&P Biotech ETF worth $443K as of Q2 2026.
Integral Investment Advisors bought 800 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $108K.
State Street SPDR S&P Biotech ETF made up 0.1% of Integral Investment Advisors's portfolio in Q2 2026, its #121 holding.
Integral Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and has held it in 5 quarters since.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.